SCHEMBL14072307

SCHEMBL14072307

C=C(C)C[C@H](O)C1COC(C)(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14064541 1.00 — —
SCHEMBL14627155 1.00 — —
SCHEMBL14072280 1.00 — —
SCHEMBL3465825 0.81 UGT2B7 (0.34) —
SCHEMBL11961355 0.79 CA2 (0.32) —
SCHEMBL13469485 0.79 GBA1 (0.32) —
SCHEMBL16371103 0.79 CA2 (0.32) —
SCHEMBL4248034 0.79 CA2 (0.32) —
SCHEMBL10074008 0.79 GBA1 (0.32) —
SCHEMBL4248027 0.79 CA2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429616-B2 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) 2008-09-30 — — US disclosed
Send feedback